02/14
Headlines

Aegerion Pharmaceuticals

Trader’s Watch List: JPMorgan (NYSE:JPM), Aegerion Pharmaceuticals (NASDAQ:AEGR), Shanda Games (NASDAQ:GAME), India Fund, Inc. (NYSE:IFN), Hawkins Inc. (NASDAQ:HWKN)

Kristen Barton03 mins

JPMorgan Chase & Co. (NYSE:JPM) has reached a $650,000 settlement with the Commodity Futures Trading Commission (: CFTC) to resolve the claims of filing falsified reports on the trading positions of some of its large traders. This settlement clears the bank of the charges made by the U.S. futures and option markets regulator. JPMorgan Chase…

Read More

Biotech Volatile Stocks: Geron Corporation (NASDAQ:GERN), Novavax (NASDAQ:NVAX), Aegerion Pharmaceuticals (NASDAQ:AEGR), CytRx Corporation (NASDAQ:CYTR)

Kevin Long02 mins

Geron Corp. (NASDAQ:GERN) stock had its “positive” rating reiterated by equities research analysts at Wells Fargo & Co. in a research note issued to investors on Thursday, American Banking News.com reports.Geron Corporation (NASDAQ:GERN) stock performance was -2.73% in last session and finished the day at $1.78. Traded volume was 7,214,860 million shares in the last…

Read More

Biotech Losers: Aegerion Pharmaceuticals (NASDAQ:AEGR), Ocera Therapeutics (NASDAQ:OCRX), Onconova Therapeutics (NASDAQ:ONTX), CYANOTECH (NASDAQ:CYAN)

Colin Pettis02 mins

Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) was a big mover last session, as its shares rose nearly 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the trend for the healthcare company since Feb 24, as the stock is now down nearly…

Read More

Biotech Losers: Aegerion Pharmaceuticals (NASDAQ:AEGR), Insys Therapeutics (NASDAQ:INSY), NPS Pharmaceuticals (NASDAQ:NPSP), XOMA Corp (NASDAQ:XOMA)

Richard Atkins02 mins

The Rosen Law Firm, P.A. reminds purchasers of Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR) between March 15, 2012 and January 9, 2014, inclusive (the “Class Period”) of the important Mach 17, 2014 lead plaintiff deadline in the class action seeking remedies under the federal securities laws. Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) stock performance was -5.40% in last session…

Read More